Melissa B Gilkey1,2, Michael J Parks3, Marjorie A Margolis4,2, Annie-Laurie McRee3, Jason V Terk5. 1. Department of Health Behavior and gilkey@email.unc.edu. 2. Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina. 3. Department of Pediatrics, Medical School, University of Minnesota, Minneapolis, Minnesota; and. 4. Department of Health Behavior and. 5. Cook Children's Health Care System, Fort Worth, Texas.
Abstract
BACKGROUND: High-quality evidence indicates that intervening with health care providers improves human papillomavirus (HPV) vaccine delivery. However, scaling up evidence-based strategies in real-world clinical practice remains challenging. We sought to improve the reach and impact of strategies for HPV vaccination quality improvement (QI) through local adaptation and implementation in a large, not-for-profit health care system. METHODS: We conducted an HPV vaccination QI program using existing materials to support physician training coupled with assessment and feedback. Local physicians with high HPV vaccination rates facilitated training, which included didactic instruction and video vignettes modeling effective communication. We randomly assigned 25 clinics with 77 physicians to the QI arm or the wait-list control arm. We used hierarchical linear models to assess HPV vaccination coverage (≥1 dose) over 6 months among patients aged 12 to 14. RESULTS:Of 45 physicians in the QI arm, the program reached 43 (95%) with training plus assessment and feedback. In the overall sample, HPV vaccination coverage increased in both the QI and control arms (8.6 vs 6.4 percentage points, respectively), although the 2.2-percentage point difference did not reach statistical significance. Sensitivity analyses that excluded physicians with poor data quality indicated a statistically significant advantage of 3.3 percentage points for QI versus control (b = 0.034; SE = 0.015; P < .05). CONCLUSIONS: Our locally adapted QI program achieved excellent reach, with small improvements in HPV vaccination coverage. Future implementation research is needed to bolster program impact and support health systems in leveraging local resources to conduct these programs efficiently.
RCT Entities:
BACKGROUND: High-quality evidence indicates that intervening with health care providers improves human papillomavirus (HPV) vaccine delivery. However, scaling up evidence-based strategies in real-world clinical practice remains challenging. We sought to improve the reach and impact of strategies for HPV vaccination quality improvement (QI) through local adaptation and implementation in a large, not-for-profit health care system. METHODS: We conducted an HPV vaccination QI program using existing materials to support physician training coupled with assessment and feedback. Local physicians with high HPV vaccination rates facilitated training, which included didactic instruction and video vignettes modeling effective communication. We randomly assigned 25 clinics with 77 physicians to the QI arm or the wait-list control arm. We used hierarchical linear models to assess HPV vaccination coverage (≥1 dose) over 6 months among patients aged 12 to 14. RESULTS: Of 45 physicians in the QI arm, the program reached 43 (95%) with training plus assessment and feedback. In the overall sample, HPV vaccination coverage increased in both the QI and control arms (8.6 vs 6.4 percentage points, respectively), although the 2.2-percentage point difference did not reach statistical significance. Sensitivity analyses that excluded physicians with poor data quality indicated a statistically significant advantage of 3.3 percentage points for QI versus control (b = 0.034; SE = 0.015; P < .05). CONCLUSIONS: Our locally adapted QI program achieved excellent reach, with small improvements in HPV vaccination coverage. Future implementation research is needed to bolster program impact and support health systems in leveraging local resources to conduct these programs efficiently.
Authors: Richard Spoth; Louise A Rohrbach; Mark Greenberg; Philip Leaf; C Hendricks Brown; Abigail Fagan; Richard F Catalano; Mary Ann Pentz; Zili Sloboda; J David Hawkins Journal: Prev Sci Date: 2013-08
Authors: Electra D Paskett; Jessica L Krok-Schoen; Michael L Pennell; Cathy M Tatum; Paul L Reiter; Juan Peng; Brittany M Bernardo; Rory C Weier; Morgan S Richardson; Mira L Katz Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-04 Impact factor: 4.254
Authors: Melissa B Gilkey; William A Calo; Jennifer L Moss; Parth D Shah; Macary W Marciniak; Noel T Brewer Journal: Vaccine Date: 2016-01-24 Impact factor: 3.641
Authors: William A Calo; Melissa B Gilkey; Jennifer Leeman; Jennifer Heisler-MacKinnon; Chrystal Averette; Stephanie Sanchez; Melanie L Kornides; Noel T Brewer Journal: Transl Behav Med Date: 2019-01-01 Impact factor: 3.046
Authors: Tanja Y Walker; Laurie D Elam-Evans; James A Singleton; David Yankey; Lauri E Markowitz; Benjamin Fredua; Charnetta L Williams; Sarah A Meyer; Shannon Stokley Journal: MMWR Morb Mortal Wkly Rep Date: 2017-08-25 Impact factor: 17.586
Authors: Lital Avni-Singer; Carlos R Oliveira; Ashlynn Torres; Eugene D Shapiro; Linda M Niccolai; Sangini S Sheth Journal: Obstet Gynecol Date: 2020-11 Impact factor: 7.623
Authors: Peter G Szilagyi; Christina S Albertin; Dennis Gurfinkel; Alison W Saville; Sitaram Vangala; John D Rice; Laura Helmkamp; Gregory D Zimet; Rebecca Valderrama; Abigail Breck; Cynthia M Rand; Sharon G Humiston; Allison Kempe Journal: Vaccine Date: 2020-08-02 Impact factor: 4.169
Authors: Jenny K R Francis; Serena A Rodriguez; Olivia Dorsey; James-Michael Blackwell; Bijal A Balasubramanian; Neelima Kale; Philip Day; Sharice M Preston; Erika L Thompson; Sandi L Pruitt; Jasmin A Tiro Journal: Prev Med Rep Date: 2021-09-17
Authors: Janet A Curran; Allyson J Gallant; Helen Wong; Hwayeon Danielle Shin; Robin Urquhart; Julia Kontak; Lori Wozney; Leah Boulos; Zulfiqar Bhutta; Etienne V Langlois Journal: BMJ Open Date: 2022-01-17 Impact factor: 2.692
Authors: Wendy Landier; Smita Bhatia; Joshua S Richman; Paula D Campos Gonzalez; Brooke Cherven; Veronica Chollette; Jamie Aye; Sharon M Castellino; Maria M Gramatges; Susan Lindemulder; Thomas B Russell; Lucie M Turcotte; Graham A Colditz; Melissa B Gilkey; James L Klosky Journal: BMC Pediatr Date: 2022-09-12 Impact factor: 2.567